Enteral Nutrition Supplemented with Transforming Growth Factor-β, Colostrum, Probiotics, and Other Nutritional Compounds in the Treatment of Patients with Inflammatory Bowel Disease
Enteral nutrition seems to play a significant role in the treatment of both adults and children with active Crohn’s disease, and to a lesser degree in the treatment of patients with active ulcerative colitis. The inclusion of some special factors in the enteral nutrition formulas might increase the...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2020-04-01
|
| Series: | Nutrients |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2072-6643/12/4/1048 |
| _version_ | 1797570934806151168 |
|---|---|
| author | John K. Triantafillidis Maria Tzouvala Eleni Triantafyllidi |
| author_facet | John K. Triantafillidis Maria Tzouvala Eleni Triantafyllidi |
| author_sort | John K. Triantafillidis |
| collection | DOAJ |
| description | Enteral nutrition seems to play a significant role in the treatment of both adults and children with active Crohn’s disease, and to a lesser degree in the treatment of patients with active ulcerative colitis. The inclusion of some special factors in the enteral nutrition formulas might increase the rate of the efficacy. Actually, enteral nutrition enriched in Transforming Growth Factor-β reduced the activity index and maintained remission in patients with Crohn’s disease. In addition, a number of experimental animal studies have shown that colostrum exerts a significantly positive result. Probiotics of a special type and a certain dosage could also reduce the inflammatory process in patients with active ulcerative colitis. Therefore, the addition of these factors in an enteral nutrition formula might increase its effectiveness. Although the use of these formulas is not supported by large clinical trials, it could be argued that their administration in selected cases as an exclusive diet or in combination with the drugs used in patients with inflammatory bowel disease could benefit the patient. In this review, the authors provide an update on the role of enteral nutrition, supplemented with Transforming Growth Factor-β, colostrum, and probiotics in patients with inflammatory bowel disease. |
| first_indexed | 2024-03-10T20:33:29Z |
| format | Article |
| id | doaj.art-fdb5634437df421ba5af74f6b4b0cb18 |
| institution | Directory Open Access Journal |
| issn | 2072-6643 |
| language | English |
| last_indexed | 2024-03-10T20:33:29Z |
| publishDate | 2020-04-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Nutrients |
| spelling | doaj.art-fdb5634437df421ba5af74f6b4b0cb182023-11-19T21:16:50ZengMDPI AGNutrients2072-66432020-04-01124104810.3390/nu12041048Enteral Nutrition Supplemented with Transforming Growth Factor-β, Colostrum, Probiotics, and Other Nutritional Compounds in the Treatment of Patients with Inflammatory Bowel DiseaseJohn K. Triantafillidis0Maria Tzouvala1Eleni Triantafyllidi2“Metropolitan General” Hospital, ZC 15562 Holargos, GreeceDepartment of Gastroenterology “St Panteleimon” General Hospital, ZC 18454 Nicea, Greece“Metropolitan General” Hospital, ZC 15562 Holargos, GreeceEnteral nutrition seems to play a significant role in the treatment of both adults and children with active Crohn’s disease, and to a lesser degree in the treatment of patients with active ulcerative colitis. The inclusion of some special factors in the enteral nutrition formulas might increase the rate of the efficacy. Actually, enteral nutrition enriched in Transforming Growth Factor-β reduced the activity index and maintained remission in patients with Crohn’s disease. In addition, a number of experimental animal studies have shown that colostrum exerts a significantly positive result. Probiotics of a special type and a certain dosage could also reduce the inflammatory process in patients with active ulcerative colitis. Therefore, the addition of these factors in an enteral nutrition formula might increase its effectiveness. Although the use of these formulas is not supported by large clinical trials, it could be argued that their administration in selected cases as an exclusive diet or in combination with the drugs used in patients with inflammatory bowel disease could benefit the patient. In this review, the authors provide an update on the role of enteral nutrition, supplemented with Transforming Growth Factor-β, colostrum, and probiotics in patients with inflammatory bowel disease.https://www.mdpi.com/2072-6643/12/4/1048enteral nutritionTGF-βcolostrumprobioticsCrohn’s diseaseulcerative colitis |
| spellingShingle | John K. Triantafillidis Maria Tzouvala Eleni Triantafyllidi Enteral Nutrition Supplemented with Transforming Growth Factor-β, Colostrum, Probiotics, and Other Nutritional Compounds in the Treatment of Patients with Inflammatory Bowel Disease Nutrients enteral nutrition TGF-β colostrum probiotics Crohn’s disease ulcerative colitis |
| title | Enteral Nutrition Supplemented with Transforming Growth Factor-β, Colostrum, Probiotics, and Other Nutritional Compounds in the Treatment of Patients with Inflammatory Bowel Disease |
| title_full | Enteral Nutrition Supplemented with Transforming Growth Factor-β, Colostrum, Probiotics, and Other Nutritional Compounds in the Treatment of Patients with Inflammatory Bowel Disease |
| title_fullStr | Enteral Nutrition Supplemented with Transforming Growth Factor-β, Colostrum, Probiotics, and Other Nutritional Compounds in the Treatment of Patients with Inflammatory Bowel Disease |
| title_full_unstemmed | Enteral Nutrition Supplemented with Transforming Growth Factor-β, Colostrum, Probiotics, and Other Nutritional Compounds in the Treatment of Patients with Inflammatory Bowel Disease |
| title_short | Enteral Nutrition Supplemented with Transforming Growth Factor-β, Colostrum, Probiotics, and Other Nutritional Compounds in the Treatment of Patients with Inflammatory Bowel Disease |
| title_sort | enteral nutrition supplemented with transforming growth factor β colostrum probiotics and other nutritional compounds in the treatment of patients with inflammatory bowel disease |
| topic | enteral nutrition TGF-β colostrum probiotics Crohn’s disease ulcerative colitis |
| url | https://www.mdpi.com/2072-6643/12/4/1048 |
| work_keys_str_mv | AT johnktriantafillidis enteralnutritionsupplementedwithtransforminggrowthfactorbcolostrumprobioticsandothernutritionalcompoundsinthetreatmentofpatientswithinflammatoryboweldisease AT mariatzouvala enteralnutritionsupplementedwithtransforminggrowthfactorbcolostrumprobioticsandothernutritionalcompoundsinthetreatmentofpatientswithinflammatoryboweldisease AT elenitriantafyllidi enteralnutritionsupplementedwithtransforminggrowthfactorbcolostrumprobioticsandothernutritionalcompoundsinthetreatmentofpatientswithinflammatoryboweldisease |